UNSPSC 51141574: Progabide

This classification denotes an anticonvulsant, antidepressive agent, antiparkinson agent, and gaba agonist with the molecular formula C17H16ClFN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38C836J57Z, chemically known as butyramide, 4-(alpha-(p-chlorophenyl)-5-fluoro-2-hydroxybenzylideneamino)- but generally known as progabide, which bears US NIH Compound Identifier 5361323. European Medicines Agency schedules Progabide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10075MIG.

UNSPSC 51141574 Progabide, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three recent opportunities solicited under this code actually cover naloxone (an opioid antagonist), safe drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which are progabide, a specific anticonvulsant medication. The mismatch suggests either a data-entry error in how opportunities were tagged or a significant gap between the code's nominal scope and actual procurement practice. No recent state and local solicitations for progabide itself appear in the available record.

The three opportunities that were incorrectly tagged under this code span different issuing bodies and procurement models: Seminole County, Florida (IFB for naloxone and drug deactivation systems with a due date of July 26, 2023), the Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescription capabilities, posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance administered by the Minnesota Department of Administration (RFP for generic pharmaceuticals and OTC products with a due date of March 26, 2026). These represent county health procurement, state HHS exploratory contracting, and multistate cooperative purchasing respectively — three distinct buying models with no single representative buyer. The geographic spread includes Florida, Texas, and Minnesota, with the cooperative purchasing contract also covering Oregon. Without valid progabide-specific opportunities, no reliable assessment of actual demand, buying frequency, or contract value under this code is possible from the current record.